258 related articles for article (PubMed ID: 12672192)
21. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
[TBL] [Abstract][Full Text] [Related]
22. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
23. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
Williams HJ; Alarcón GS; Neuner R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; Polisson RP; Willkens RF; Yarboro C; Morgan J; Egger MJ; Ward JR
J Rheumatol; 1998 Feb; 25(2):261-8. PubMed ID: 9489817
[TBL] [Abstract][Full Text] [Related]
24. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
25. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
27. [Autoantibodies and peripheral arterial occlusive disease].
Kroeger K; Kreuzfelder E
Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
[TBL] [Abstract][Full Text] [Related]
28. Critical appraisal of the pattern of antinuclear antibodies (ANA) testing requested over a six month period at the "Escola Paulista de Medicina" (EPM), São Paulo.
Quaresma MR; Krauthamer A; Ferraz MB; Leser PG; Atra E
Rev Paul Med; 1993; 111(3):391-6. PubMed ID: 8108631
[TBL] [Abstract][Full Text] [Related]
29. Raynaud's phenomenon as an early sign of connective tissue diseases.
Kallenberg CG
Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
[TBL] [Abstract][Full Text] [Related]
30. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
31. [Raynaud phenomenon in childhood: review and progress control in eight cases].
González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
[TBL] [Abstract][Full Text] [Related]
34. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
[TBL] [Abstract][Full Text] [Related]
35. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
36. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
Moder KG; Wener MH; Weisman MH; Ishimori ML; Wallace DJ; Buckeridge DL; Homburger HA
J Rheumatol; 2007 May; 34(5):978-86. PubMed ID: 17407218
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
Haroon N; Nisha RS; Chandran V; Bharadwaj A
J Postgrad Med; 2005; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
[TBL] [Abstract][Full Text] [Related]
38. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
39. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
40. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
